No, not for younger men: the risk of myocarditis from the vaccine does not appear to offset the benefit. So if you only care about that one single dimension, younger men shouldn’t have the vaccine. That said, other costs and benefits matter far far more I think.

Absolutely terrible reporting in that link - instead look at the paper: https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA....

  In men younger than 40 years, we estimate an additional 4 and 14 myocarditis events per million in the 1 to 28 days after a first dose of BNT162b2 and mRNA-1273, respectively; and an additional 14 , 11 and 97 myocarditis events after a second dose of ChAdOx1, BNT162b2, and mRNA-1273, respectively. These estimates compare with an additional 16 myocarditis events per million men younger than 40 years in the 1 to 28 days after a SARS-CoV-2–positive test before vaccination. [ChAdOx1 == AstraZeneca, BNT162b2 == Pfizer, and mRNA-1273 == Moderna]

  The risk of vaccine-associated myocarditis is consistently higher in younger men, particularly after a second dose of mRNA-1273, where the number of additional events during 28 days was estimated to be 97 per million people exposed. An important consideration for this group is that the risk of myocarditis after a second dose of mRNA-1273 was higher than the risk after infection.

Disclaimer: I try to be apolitical however there is a strong aura of bullshit around this topic so double check everything!